European Patent Granted for Innate`s Drug Candidate AMP-886
(WorldNews Health)

ABN 16 165 160 841 ASX RELEASE 23 July 2018 European Patent Granted for Innate`s drug candidate AMP-886 Innate Immunotherapeutics Limited (ASX: IIL) is pleased to announce the European Patent Office (EPO) decision to grant a patent with respect to the Company`s drug candidate AMP-886. Importantly, the patent claims the composition of AMP-886 and also processes for the preparation of the compound or pharmaceutical compositions containing the compound. The patent also claims the use of AMP-886 to...